SQ Administration of Daratumumab: New Option for Patients

A recent study found that patients receiving Daratumumab treatment may benefit from an alternative dosing technique of subcutaneous (SQ) administration vs. the traditional IV infusion. ¬†Clinicians should be aware of advancing developments that have the potential to reduce the treatment burden and positively impact a patient’s quality of life. READ MORE HERE


Victoria has blogged 1120 posts